younger patients

  •  

    New Insights on Lung Cancer in Younger Patients

    Emma Shtivelman, PhD

    Lung cancer—in particular, non-small cell lung cancer (NSCLC)—in young people is a topic of great interest. It has been made even more so by the recent publication of a study in The Journal of the American Medical Association (JAMA) that analyzed over 2,000 NSCLC patients of all ages and resulted in two major conclusions: First, that younger patients (less than 40 years old) have a higher frequency of targetable mutations. Second, that they have relatively poor survival when compared to older patients, except those older than 70 years.